Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Angshuman Mukherjee (Kolkata, India), Angshuman Mukherjee, Samim Khan, Sumitra Basuthakur, Raja Dhar. A cross-sectional study on association between stable COPD & metabolic syndrome (Syndrome X). Eur Respir J 2015; 46: Suppl. 59, 3978

Member's Comments

No comment yet.

Related content which might interest you: Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Lung function (LF) decline and hospitalization in subjects with the asthma-COPD overlap syndrome Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Prevalence of metabolic syndrome (MS) in a population of apneic patients:A prospective study with cardiovascular risk estimation Source: International Congress 2014 – Sleep disordered breathing 4 Year: 2014 Asthma-COPD overlap syndrome (ACOS) versus ²pure² COPD: A distinct phenotype? Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 Differences between asthma-COPD overlap syndrome (ACOS) and adult-onset asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Pharmacogenetic and clinicopathological markers of BA-COPD (overlap syndrome) Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 15-years mortality in asthma-COPD overlap syndrome (ACOS) elderly population Source: International Congress 2015 – Respiratory health across the life course Year: 2015 COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Associations between severity of airflow obstruction and atherosclerosis: A cross-sectional study in Japan Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Metabolic syndrome in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 Phenotypic and molecular-genetic features of asthma-COPD overlap syndrome (ACOS) Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Comorbidities and burden of COPD: A population based case-control study Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Risk scores for predicting death in COPD patients Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Comorbidities, gender-differences and COPD severity: The French Palomb cohort Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Risk of CAP in COPD stratified by smoking status: A population-based cohort study in the UK Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 The characteristics of ACOS in a population based asthma cohort Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016